申请人:Arrys Therapeutics, Inc.
公开号:US20190314390A1
公开(公告)日:2019-10-17
The present invention provides use of an agent that inhibits EP4 activity and an immuno-oncology agent, or a composition thereof, for treatment of a cancer.
本发明提供了一种使用抑制EP4活性的药剂和免疫肿瘤药剂或其组合物用于治疗癌症的方法。